Iterum Therapeutics plc (ITRMF) Total Liabilities (2017 - 2025)

Iterum Therapeutics' Total Liabilities history runs 9 years deep, the most recent figure standing at $39.9 million for Q3 2025.

• In Q3 2025, Total Liabilities rose 45.4% year-over-year to $39.9 million; the TTM figure through Sep 2025 stood at $39.9 million (up 45.4% YoY), while the FY2024 annual figure was $48.7 million, up 49.03% from the prior year.
• Total Liabilities for Q3 2025 stood at $39.9 million, up from $37.9 million in the prior quarter.
• The five-year high for Total Liabilities was $83.6 million in Q1 2021, with the low at $25.1 million in Q2 2024.
• The 5-year median for Total Liabilities is $38.8 million (2022), against an average of $40.4 million.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities tumbled 57.65% in 2022, then jumped 51.08% in 2025.
• Iterum Therapeutics' Total Liabilities stood at $41.3 million in 2021, then decreased by 5.91% to $38.8 million in 2022, then decreased by 15.89% to $32.7 million in 2023, then soared by 49.03% to $48.7 million in 2024, then retreated by 18.06% to $39.9 million in 2025.
• Business Quant data shows ITRMF's Total Liabilities at $39.9 million in Q3 2025, $37.9 million in Q2 2025, and $35.5 million in Q1 2025.